Target Application ‘Optical Coherence Tomography (OCT) in Retina & Skin Diagnostics’ Offers Great Market Dynamics for PI

Dear Colleagues,

In our ‘blue-line webinar’ in April, we highlighted the topical market dynamics in the target application ‘Optical Coherence Tomography (OCT) in Retina & Skin Diagnostics’. This target application is part of the subsegment ‘Endoscopy & in vivo diagnostics’ and currently offers great chances for PI to further strengthen our share of market (SOM).

As the OCT method – first introduced to the market by Carl Zeiss Meditec in 1996 - became the ‘Gold Standard’ in retina inspection around 2006, now OCT is about to also become the gold standard for skin cancer diagnostics. This will go along with a boost in demand for z-precision drives in the near future. Such drives play a crucial role in the OCT technology. Here PI offers standard products as PIFOCs and HERAs  and can also offer very specific, cost targeted solutions.

Learn more about OCT, its application in ophthalmology and dermatology, and our offering in the market, on our dedicated landingpage ‘Optical Coherence Tomography‘.

Best regards
Dr. Thomas Bocher
Director of Segment Marketing - Global & Global Head of Segment Marketing Microscopy & Life Sciences